An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in AdolescenceLourdes Ibáñez, Peter A. Lee, Sharon E. Oberfield et al.|Hormone Research in Paediatrics|2017Cited by 451
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 TrialHelena W. Rodbard, Е. О. Филиппова, Julio Rosenstock et al.|Diabetes Care|2019Cited by 442
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE)Massimiliano Caprio, Riccarda Granata, Eleonora Poggiogalle et al.|Journal of Endocrinological Investigation|2019Cited by 292
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 DiabetesAlessandra Gambineri, Renato Pasquali, Laura Patton et al.|Diabetes|2012Cited by 225